Weekly News Roundup – Real-World Wins and Billion-Dollar Breakthroughs
Update: 2025-10-24
Description
This week’s tHEORetically Speaking News Roundup covers Astellas Pharma’s Phase 4 findings showing fezolinetant’s real-world benefits for menopausal symptom relief, improved sleep, and daily functioning. We also dive into Takeda’s $11 billion collaboration with Innovent Biologics to advance next-generation cancer therapies and expand its global oncology pipeline.
Tune in for this concise recap of these pivotal industry updates!
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
